 | • レポートコード：B-GIR08C2919 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、イブルチニブの世界市場について調べ、まとめました。種類別セグメントは、90カプセル/箱、120カプセル/箱等、用途別セグメントは、マントル細胞リンパ腫、慢性リンパ性白血病、小リンパ性リンパ腫、その他等に区分しました。イブルチニブの世界市場概観、企業動向、企業別イブルチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・イブルチニブの市場概観 ・イブルチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・イブルチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・イブルチニブの世界市場規模 ・イブルチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・イブルチニブのアメリカ市場規模推移 ・イブルチニブのカナダ市場規模推移 ・イブルチニブのメキシコ市場規模推移 ・イブルチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・イブルチニブのドイツ市場規模推移 ・イブルチニブのイギリス市場規模推移 ・イブルチニブのロシア市場規模推移 ・イブルチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・イブルチニブの日本市場規模推移 ・イブルチニブの中国市場規模推移 ・イブルチニブの韓国市場規模推移 ・イブルチニブのインド市場規模推移 ・イブルチニブの東南アジア市場規模推移 ・イブルチニブの南米市場分析（ブラジル、アルゼンチン等） ・イブルチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・イブルチニブの種類別分析/販売量、売上、市場シェア（90カプセル/箱、120カプセル/箱） ・イブルチニブの用途別分析/市場規模（マントル細胞リンパ腫、慢性リンパ性白血病、小リンパ性リンパ腫、その他） ・イブルチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・イブルチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Ibrutinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ibrutinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Beacon Pharmaceuticals
Janssen Pharmaceuticals
Incepta Pharmaceuticals
Pharmacyclics Inc
Bluepharma
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
90 Capsules/Box
120 Capsules/Box
Market Segment by Applications, can be divided into
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ibrutinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ibrutinib, with price, sales, revenue and global market share of Ibrutinib in 2017 and 2018.
Chapter 3, the Ibrutinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ibrutinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ibrutinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ibrutinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ibrutinib Introduction
1.2 Market Analysis by Type
1.2.1 90 Capsules/Box
1.2.2 120 Capsules/Box
1.3 Market Analysis by Applications
1.3.1 Mantle Cell Lymphoma
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Small Lymphocytic Lymphoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Beacon Pharmaceuticals
2.1.1 Business Overview
2.1.2 Ibrutinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Beacon Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Janssen Pharmaceuticals
2.2.1 Business Overview
2.2.2 Ibrutinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Janssen Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Incepta Pharmaceuticals
2.3.1 Business Overview
2.3.2 Ibrutinib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Incepta Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pharmacyclics Inc
2.4.1 Business Overview
2.4.2 Ibrutinib Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pharmacyclics Inc Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bluepharma
2.5.1 Business Overview
2.5.2 Ibrutinib Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bluepharma Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Ibrutinib Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ibrutinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Ibrutinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Ibrutinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Ibrutinib Manufacturer Market Share in 2018
3.3.2 Top 6 Ibrutinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Ibrutinib Market Analysis by Regions
4.1 Global Ibrutinib Sales, Revenue and Market Share by Regions
4.1.1 Global Ibrutinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Ibrutinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Ibrutinib Sales and Growth Rate (2014-2019)
4.3 Europe Ibrutinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Ibrutinib Sales and Growth Rate (2014-2019)
4.5 South America Ibrutinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Ibrutinib Sales and Growth Rate (2014-2019)
5 North America Ibrutinib by Country
5.1 North America Ibrutinib Sales, Revenue and Market Share by Country
5.1.1 North America Ibrutinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Ibrutinib Revenue and Market Share by Country (2014-2019)
5.2 United States Ibrutinib Sales and Growth Rate (2014-2019)
5.3 Canada Ibrutinib Sales and Growth Rate (2014-2019)
5.4 Mexico Ibrutinib Sales and Growth Rate (2014-2019)
6 Europe Ibrutinib by Country
6.1 Europe Ibrutinib Sales, Revenue and Market Share by Country
6.1.1 Europe Ibrutinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Ibrutinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Ibrutinib Sales and Growth Rate (2014-2019)
6.3 UK Ibrutinib Sales and Growth Rate (2014-2019)
6.4 France Ibrutinib Sales and Growth Rate (2014-2019)
6.5 Russia Ibrutinib Sales and Growth Rate (2014-2019)
6.6 Italy Ibrutinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ibrutinib by Country
7.1 Asia-Pacific Ibrutinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Ibrutinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Ibrutinib Revenue and Market Share by Country (2014-2019)
7.2 China Ibrutinib Sales and Growth Rate (2014-2019)
7.3 Japan Ibrutinib Sales and Growth Rate (2014-2019)
7.4 Korea Ibrutinib Sales and Growth Rate (2014-2019)
7.5 India Ibrutinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Ibrutinib Sales and Growth Rate (2014-2019)
8 South America Ibrutinib by Country
8.1 South America Ibrutinib Sales, Revenue and Market Share by Country
8.1.1 South America Ibrutinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Ibrutinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Ibrutinib Sales and Growth Rate (2014-2019)
8.3 Argentina Ibrutinib Sales and Growth Rate (2014-2019)
8.4 Colombia Ibrutinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ibrutinib by Countries
9.1 Middle East and Africa Ibrutinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Ibrutinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Ibrutinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Ibrutinib Sales and Growth Rate (2014-2019)
9.3 Turkey Ibrutinib Sales and Growth Rate (2014-2019)
9.4 Egypt Ibrutinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Ibrutinib Sales and Growth Rate (2014-2019)
9.6 South Africa Ibrutinib Sales and Growth Rate (2014-2019)
10 Global Ibrutinib Market Segment by Type
10.1 Global Ibrutinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Ibrutinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Ibrutinib Revenue and Market Share by Type (2014-2019)
10.2 90 Capsules/Box Sales Growth and Price
10.2.1 Global 90 Capsules/Box Sales Growth (2014-2019)
10.2.2 Global 90 Capsules/Box Price (2014-2019)
10.3 120 Capsules/Box Sales Growth and Price
10.3.1 Global 120 Capsules/Box Sales Growth (2014-2019)
10.3.2 Global 120 Capsules/Box Price (2014-2019)
11 Global Ibrutinib Market Segment by Application
11.1 Global Ibrutinib Sales Market Share by Application (2014-2019)
11.2 Mantle Cell Lymphoma Sales Growth (2014-2019)
11.3 Chronic Lymphocytic Leukemia Sales Growth (2014-2019)
11.4 Small Lymphocytic Lymphoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Ibrutinib Market Forecast (2019-2024)
12.1 Global Ibrutinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Ibrutinib Market Forecast by Regions (2019-2024)
12.2.1 North America Ibrutinib Market Forecast (2019-2024)
12.2.2 Europe Ibrutinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Ibrutinib Market Forecast (2019-2024)
12.2.4 South America Ibrutinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Ibrutinib Market Forecast (2019-2024)
12.3 Ibrutinib Market Forecast by Type (2019-2024)
12.3.1 Global Ibrutinib Sales Forecast by Type (2019-2024)
12.3.2 Global Ibrutinib Market Share Forecast by Type (2019-2024)
12.4 Ibrutinib Market Forecast by Application (2019-2024)
12.4.1 Global Ibrutinib Sales Forecast by Application (2019-2024)
12.4.2 Global Ibrutinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Ibrutinib Picture
Table Product Specifications of Ibrutinib
Figure Global Sales Market Share of Ibrutinib by Types in 2018
Table Ibrutinib Types for Major Manufacturers
Figure 90 Capsules/Box Picture
Figure 120 Capsules/Box Picture
Figure Ibrutinib Sales Market Share by Applications in 2018
Figure Mantle Cell Lymphoma Picture
Figure Chronic Lymphocytic Leukemia Picture
Figure Small Lymphocytic Lymphoma Picture
Figure Other Picture
Figure United States Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Ibrutinib Revenue (Value) and Growth Rate (2014-2024)
Table Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Beacon Pharmaceuticals Ibrutinib Type and Applications
Table Beacon Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals Ibrutinib Type and Applications
Table Janssen Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Incepta Pharmaceuticals Ibrutinib Type and Applications
Table Incepta Pharmaceuticals Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pharmacyclics Inc Basic Information, Manufacturing Base and Competitors
Table Pharmacyclics Inc Ibrutinib Type and Applications
Table Pharmacyclics Inc Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bluepharma Basic Information, Manufacturing Base and Competitors
Table Bluepharma Ibrutinib Type and Applications
Table Bluepharma Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Ibrutinib Type and Applications
Table Johnson & Johnson Ibrutinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ibrutinib Sales by Manufacturer (2017-2018)
Figure Global Ibrutinib Sales Market Share by Manufacturer in 2017
Figure Global Ibrutinib Sales Market Share by Manufacturer in 2018
Table Global Ibrutinib Revenue by Manufacturer (2017-2018)
Figure Global Ibrutinib Revenue Market Share by Manufacturer in 2017
Figure Global Ibrutinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Ibrutinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Ibrutinib Manufacturer (Revenue) Market Share in 2018
Figure Global Ibrutinib Sales and Growth Rate (2014-2019)
Figure Global Ibrutinib Revenue and Growth Rate (2014-2019)
Table Global Ibrutinib Sales by Regions (2014-2019)
Table Global Ibrutinib Sales Market Share by Regions (2014-2019)
Table Global Ibrutinib Revenue by Regions (2014-2019)
Figure Global Ibrutinib Revenue Market Share by Regions (2014-2019)
Figure Global Ibrutinib Revenue Market Share by Regions in 2018
Figure North America Ibrutinib Sales and Growth Rate (2014-2019)
Figure Europe Ibrutinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ibrutinib Sales and Growth Rate (2014-2019)
Figure South America Ibrutinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ibrutinib Sales and Growth Rate (2014-2019)
Figure North America Ibrutinib Revenue and Growth Rate (2014-2019)
Table North America Ibrutinib Sales by Countries (2014-2019)
Table North America Ibrutinib Sales Market Share by Countries (2014-2019)
Figure North America Ibrutinib Sales Market Share by Countries (2014-2019)
Figure North America Ibrutinib Sales Market Share by Countries in 2018
Table North America Ibrutinib Revenue by Countries (2014-2019)
Table North America Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure North America Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure North America Ibrutinib Revenue Market Share by Countries in 2018
Figure United States Ibrutinib Sales and Growth Rate (2014-2019)
Figure Canada Ibrutinib Sales and Growth Rate (2014-2019)
Figure Mexico Ibrutinib Sales and Growth Rate (2014-2019)
Figure Europe Ibrutinib Revenue and Growth Rate (2014-2019)
Table Europe Ibrutinib Sales by Countries (2014-2019)
Table Europe Ibrutinib Sales Market Share by Countries (2014-2019)
Table Europe Ibrutinib Revenue by Countries (2014-2019)
Figure Europe Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure Europe Ibrutinib Revenue Market Share by Countries in 2018
Figure Germany Ibrutinib Sales and Growth Rate (2014-2019)
Figure UK Ibrutinib Sales and Growth Rate (2014-2019)
Figure France Ibrutinib Sales and Growth Rate (2014-2019)
Figure Russia Ibrutinib Sales and Growth Rate (2014-2019)
Figure Italy Ibrutinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ibrutinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ibrutinib Sales by Countries (2014-2019)
Table Asia-Pacific Ibrutinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Ibrutinib Sales Market Share by Countries 2018
Table Asia-Pacific Ibrutinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Ibrutinib Revenue Market Share by Countries 2018
Figure China Ibrutinib Sales and Growth Rate (2014-2019)
Figure Japan Ibrutinib Sales and Growth Rate (2014-2019)
Figure Korea Ibrutinib Sales and Growth Rate (2014-2019)
Figure India Ibrutinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Ibrutinib Sales and Growth Rate (2014-2019)
Figure South America Ibrutinib Revenue and Growth Rate (2014-2019)
Table South America Ibrutinib Sales by Countries (2014-2019)
Table South America Ibrutinib Sales Market Share by Countries (2014-2019)
Figure South America Ibrutinib Sales Market Share by Countries in 2018
Table South America Ibrutinib Revenue by Countries (2014-2019)
Table South America Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure South America Ibrutinib Revenue Market Share by Countries in 2018
Figure Brazil Ibrutinib Sales and Growth Rate (2014-2019)
Figure Argentina Ibrutinib Sales and Growth Rate (2014-2019)
Figure Colombia Ibrutinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ibrutinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ibrutinib Sales by Countries (2014-2019)
Table Middle East and Africa Ibrutinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Ibrutinib Sales Market Share by Countries in 2018
Table Middle East and Africa Ibrutinib Revenue by Countries (2014-2019)
Table Middle East and Africa Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ibrutinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ibrutinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ibrutinib Sales and Growth Rate (2014-2019)
Figure UAE Ibrutinib Sales and Growth Rate (2014-2019)
Figure Egypt Ibrutinib Sales and Growth Rate (2014-2019)
Figure Nigeria Ibrutinib Sales and Growth Rate (2014-2019)
Figure South Africa Ibrutinib Sales and Growth Rate (2014-2019)
Table Global Ibrutinib Sales by Type (2014-2019)
Table Global Ibrutinib Sales Share by Type (2014-2019)
Table Global Ibrutinib Revenue by Type (2014-2019)
Table Global Ibrutinib Revenue Share by Type (2014-2019)
Figure Global 90 Capsules/Box Sales Growth (2014-2019)
Figure Global 90 Capsules/Box Price (2014-2019)
Figure Global 120 Capsules/Box Sales Growth (2014-2019)
Figure Global 120 Capsules/Box Price (2014-2019)
Table Global Ibrutinib Sales by Application (2014-2019)
Table Global Ibrutinib Sales Share by Application (2014-2019)
Figure Global Chronic Lymphocytic Leukemia Sales Growth (2014-2019)
Figure Global Small Lymphocytic Lymphoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Ibrutinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Ibrutinib Sales Forecast by Regions (2019-2024)
Table Global Ibrutinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Ibrutinib Market Forecast (2019-2024)
Figure Europe Sales Ibrutinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Ibrutinib Market Forecast (2019-2024)
Figure South America Sales Ibrutinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Ibrutinib Market Forecast (2019-2024)
Table Global Ibrutinib Sales Forecast by Type (2019-2024)
Table Global Ibrutinib Market Share Forecast by Type (2019-2024)
Table Global Ibrutinib Sales Forecast by Application (2019-2024)
Table Global Ibrutinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
びまん性大細胞型B細胞リンパ腫薬市場：世界及び中国市場分析・予測（～2024年） Diffuse Large B Cell Lymphoma Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Diffuse Large B Cell Lymphoma Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the …- 世界のインブルビカ市場：市場規模・現状・予測 Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.In 2018, the global Imbruvica ma…
- 蒸気カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vapor Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vapor Capsules in global…
- HPMCカプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow produ…
- 世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…